SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
649But let me re-iterate that I'm just quoting from the SEC form here - I have Biomaven-8/25/2006
648Thanks for that Peter. I always assumed they reported Street Name accounts - otRobohogs-8/25/2006
647That wasn't the SEC's intention when they introduced the 13f: <i>Biomaven-8/25/2006
646That is true - ALXN is borrowable at MBTrading = Penson, and they're not thetom pope-8/25/2006
645I checked with a broker who posts here and got this response: <i>Most likIan@SI-8/25/2006
644Don't the street name shares get filed with the 13Fs with statement to no voRobohogs-8/25/2006
643Possibly >>Failure-to-deliver shares .. naked shorts. This increases the LJM-8/25/2006
642>>Shorted shares increase the total number some I added those in. There IRWIN JAMES FRANKEL-8/25/2006
641<i>shares held in street name in your brokerage account are counted as InsBiomaven-8/25/2006
640That would explain it. I did not know that and thought that these figures only IRWIN JAMES FRANKEL-8/25/2006
639IJ, I believe that the shares held in street name in your brokerage account arIan@SI-8/24/2006
638Shares outstanding (Yahoo) 31.54M SI 3.76M Total shares ownable 35.3M SharesIRWIN JAMES FRANKEL-8/24/2006
637Drugmaker to pour millions into facility A Connecticut-based biotechnology compIcebrg-8/10/2006
636Hi Rareearth, Thanks for your reply.I`ve invested in biotechs since 1984,and thrpraxsis-7/31/2006
635praxsis, Thanks for your kind comments, I do have a few other companies I'vrareearth42-7/27/2006
634Rareearth: Sorry to hear you are out of ALXN.As I said in my previous post,your praxsis-7/26/2006
633Hello A.B I have to admit I sold all my ALXN at $36 and change to take my profrareearth42-7/25/2006
632Hi Rareearth, Have always enjoyed reading your posts on the yahoo board(it wasn`praxsis-7/24/2006
631Hello W54, I'm here reading the boards, but haven't decided what e-mail rareearth42-7/18/2006
630RE42, Give a shout when you can. W54keokalani'nui-7/17/2006
629>>Alexion Reports Phase III Preliminary Results for APEX-AMI Study>>Icebrg-6/28/2006
628Alexion Reports Phase III Preliminary Results for APEX-AMI Study June 28, 2006LJM-6/28/2006
627Alexion Announces the EXPLORE Clinical Diagnostic Study for Paroxysmal Nocturnalkeokalani'nui-6/16/2006
626Prevention of C5 activation ameliorates spontaneous and experimental glomeruloneIcebrg-6/15/2006
625Alexion Announces Pre-Clinical Results with Novel Anti-Cancer Antibody; TreatmenIcebrg-6/6/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News